Cerus (CERS) Return on Capital Employed (2011 - 2026)
Cerus (CERS) reported Return on Capital Employed of 2.77% for Q1 2026, up 625.0% on a YoY basis from 0.38% in Q1 2025, and up 62.48% sequentially from 7.37% in Q4 2025.
Cerus (CERS) Return on Capital Employed (2011 - 2026) Analysis & Trends
Cerus (CERS) has 16 years of Return on Capital Employed data on file, last reported at 2.77% in Q1 2026.
- For the quarter ending Q1 2026, Return on Capital Employed rose 625.0% year-over-year to 2.77%; the trailing twelve-month figure through Mar 2026 stood at 2.77% (up 625.0% YoY), and the FY2025 full-year result was 7.85%, up 263.0% from the prior year.
- Return on Capital Employed climbed to 2.77% in Q1 2026, from 7.37% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 2.77% in Q1 2026 to a low of 34.19% in Q4 2022.
- A 5-year average of 18.45% and a median of 17.54% in 2024 frame the typical range for Return on Capital Employed.
- Across the five-year window, Return on Capital Employed tumbled 862 bps in 2023 and surged 2467 bps in 2024, its largest moves.
- Tracing CERS's Return on Capital Employed over 5 years: stood at 34.19% in 2022, then jumped by 35 bps to 22.38% in 2023, then jumped by 52 bps to 10.81% in 2024, then soared by 32 bps to 7.37% in 2025, then surged by 62 bps to 2.77% in 2026.
- Business Quant data shows CERS's Return on Capital Employed at 2.77% in Q1 2026, 7.37% in Q4 2025, and 7.55% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.44 Bn | 175.14 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 128.87 Bn | 125.99 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 108.10 Bn | 98.88 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 67.99 Bn | 66.53 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 48.22 Bn | 44.55 Bn | 1.29 Bn | 11.13% |
| 6 | Dexcom | 28.26 Bn | 27.15 Bn | 750.30 Mn | 24.24% |
| 7 | GE HealthCare Technologies | 28.02 Bn | 25.74 Bn | 1.98 Bn | 9.30% |
| 8 | Smith & Nephew | 27.01 Bn | 26.43 Bn | - | - |
| 9 | Koninklijke Philips | 23.74 Bn | 20.62 Bn | 2.07 Bn | 8.38% |
| 10 | Cerus | 604.75 Mn | 524.33 Mn | 27.89 Mn | -2.77% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.77% |
| Dec 31, 2025 | -7.37% |
| Sep 30, 2025 | -7.55% |
| Jun 30, 2025 | -9.31% |
| Mar 31, 2025 | -9.02% |
| Dec 31, 2024 | -10.81% |
| Sep 30, 2024 | -8.86% |
| Jun 30, 2024 | -12.05% |
| Mar 31, 2024 | -17.54% |
| Dec 31, 2023 | -22.38% |
| Sep 30, 2023 | -33.53% |
| Jun 30, 2023 | -33.47% |
| Mar 31, 2023 | -28.19% |
| Dec 31, 2022 | -34.19% |
| Sep 30, 2022 | -25.71% |
| Jun 30, 2022 | -24.85% |
| Mar 31, 2022 | -25.97% |
| Dec 31, 2021 | -32.70% |
| Sep 30, 2021 | -36.01% |
| Jun 30, 2021 | -37.91% |